// App-Quantinova.ai

: Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

Researchers

Presenter

  • Pier Luigi Zinzani

Principal Investigators

  • Armando Santoro

  • Luigina Mollica

  • Sirpa Lepp

  • George A Follows

  • Georg Lenz

  • Won Seog Kim

  • Arnon Nagler

  • Panayiotis Panayiotidis

  • Judit Demeter

  • Franck Morschhauser

  • Liana Rodrigues

  • John Reeves

  • Florian Hiemeyer

  • Ashok Miriyala

  • Jose Garcia-Vargas

  • Barrett H. Childs

  • Martin H. Dreyling

Medical Centers

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Medical Oncology, IRCCS Humanitas Institute, Rozzano, Milan, Italy

  • Maisonneuve-Rosemont Hospital Research Center, Montreal, Canada

  • Helsinki University Hospital, Helsinki, Finland

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Translational Oncology, University Hospital Munster, Munster, Germany

  • Sungkyunkwan university school of medicine, samsung medical center, Seoul, Korea (the Republic of)

  • Chaim Sheba Medical Center-Tel Aviv University, Tel-Hashomer, Israel

  • National and Kapodistrian University of Athens, Athens, Greece

  • Semmelweis University, Budapest, Hungary

  • Hopital Claude Huriez, Lille, France

  • Bayer SA, Sao Paulo, Brazil

  • Joule INC, Edison, NJ

  • Bayer AG, Pharmaceuticals Division, Wuppertal, Germany

  • Bayer HealthCare Pharmaceuticals, Whippany, NJ

  • Klinikum Der Universität München-Grosshadern, Medizinische Klinik und Poliklinik III, München, Germany

Locations

  • Italy

  • Canada

  • Finland

  • United Kingdom

  • Germany

  • Republic of South Korea

  • Israel

  • Greece

  • Hungary

  • France

  • Brazil

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • B-Cell Non-Hodgkin Lymphoma

  • B cell lymphomas

  • Hypertension

  • Non‐Hodgkin Lymphoma

  • Diabetes

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Copanlisib

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved